- Home
- ANVS vs PED Comparison
ANVS vs PED Comparison
Compare ANVS & PED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANVS
- PED
- Stock Information
- Founded
- ANVS 2008
- PED N/A
- Country
- ANVS United States
- PED United States
- Employees
- ANVS N/A
- PED N/A
- Industry
- ANVS Biotechnology: Pharmaceutical Preparations
- PED Oil & Gas Production
- Sector
- ANVS Health Care
- PED Energy
- Exchange
- ANVS Nasdaq
- PED Nasdaq
- Market Cap
- ANVS 44.6M
- PED 48.8M
- IPO Year
- ANVS 2020
- PED N/A
- Fundamental
- Price
- ANVS $2.36
- PED $0.64
- Analyst Decision
- ANVS Strong Buy
- PED Strong Buy
- Analyst Count
- ANVS 5
- PED 2
- Target Price
- ANVS $30.25
- PED $1.63
- AVG Volume (30 Days)
- ANVS 485.7K
- PED 572.9K
- Earning Date
- ANVS 08-14-2025
- PED 08-13-2025
- Dividend Yield
- ANVS N/A
- PED N/A
- EPS Growth
- ANVS N/A
- PED 2248.88
- EPS
- ANVS N/A
- PED 0.19
- Revenue
- ANVS N/A
- PED $40,173,000.00
- Revenue This Year
- ANVS N/A
- PED N/A
- Revenue Next Year
- ANVS N/A
- PED $5.99
- P/E Ratio
- ANVS N/A
- PED $3.36
- Revenue Growth
- ANVS N/A
- PED 30.70
- 52 Week Low
- ANVS $1.11
- PED $0.47
- 52 Week High
- ANVS $17.88
- PED $1.10
- Technical
- Relative Strength Index (RSI)
- ANVS 48.29
- PED 51.04
- Support Level
- ANVS $2.05
- PED $0.63
- Resistance Level
- ANVS $3.18
- PED $0.67
- Average True Range (ATR)
- ANVS 0.26
- PED 0.05
- MACD
- ANVS -0.08
- PED -0.01
- Stochastic Oscillator
- ANVS 27.43
- PED 22.62
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.
About PED Pedevco Corp.
PEDEVCO Corp is an oil and gas company focused on oil and natural gas development, exploration, and production. The company focuses on legacy properties where there is a long production history, well-defined geology and existing infrastructure that can be leveraged when applying modern field management technologies. The current properties of the company are located in the San Andres formation of the Permian Basin, situated in West Texas and eastern New Mexico (the Permian Basin), and in the Denver-Julesberg Basin (D-J Basin) in Colorado and Wyoming.